Clearwater Paper Swings to $53.3M Loss on Goodwill Impairment

Ticker: CLW · Form: 10-Q · Filed: Oct 28, 2025 · CIK: 1441236

Sentiment: bearish

Topics: Paperboard, Goodwill Impairment, Net Loss, Cash Flow, Acquisition Integration, Discontinued Operations, Manufacturing

Related Tickers: CLW

TL;DR

**Clearwater Paper's massive goodwill impairment and cash drain make it a risky bet despite revenue growth; steer clear until integration benefits materialize.**

AI Summary

Clearwater Paper Corp (CLW) reported a significant net loss of $53.3 million for the quarter ended September 30, 2025, a sharp decline from a net income of $5.8 million in the same period last year. This substantial loss was primarily driven by a $48.0 million goodwill impairment charge. Despite the net loss, net sales from continuing operations increased to $399.0 million for the quarter, up from $393.3 million in Q3 2024, and rose to $1,169.0 million for the nine months ended September 30, 2025, compared to $996.5 million in the prior year. The company's cash and cash equivalents decreased from $79.6 million at December 31, 2024, to $34.4 million at September 30, 2025. Long-term debt, net, increased from $281.6 million to $335.5 million over the same period. The sale of its tissue operations in November 2024, now classified as discontinued operations, contributed $0.6 million in income for the quarter, down from $16.6 million in Q3 2024, reflecting the settlement of contractual and employment-related obligations. The acquisition of the Augusta, Georgia paperboard manufacturing facility in May 2024, for a final purchase price of $708.2 million, is a key strategic move, though its full benefits are still being integrated.

Why It Matters

Clearwater Paper's substantial net loss of $53.3 million, largely due to a $48.0 million goodwill impairment, signals potential challenges in asset valuation and profitability for investors. While net sales from continuing operations saw a modest increase, the significant cash burn, with cash and cash equivalents dropping from $79.6 million to $34.4 million, raises liquidity concerns. The company's strategic shift away from tissue operations and the integration of the Augusta paperboard facility are critical for its future, but the impairment suggests that the market or internal projections for some assets may be underperforming. This could impact employee morale, customer confidence in long-term stability, and potentially shift competitive dynamics within the North American bleached paperboard market.

Risk Assessment

Risk Level: high — The company reported a net loss of $53.3 million for the quarter ended September 30, 2025, primarily due to a $48.0 million goodwill impairment. Cash and cash equivalents significantly decreased from $79.6 million at December 31, 2024, to $34.4 million at September 30, 2025, indicating substantial cash burn and potential liquidity issues.

Analyst Insight

Investors should exercise caution and thoroughly evaluate Clearwater Paper's ability to generate sustainable cash flow from its continuing operations. Monitor the integration progress of the Augusta facility and the realization of anticipated synergies, as these are crucial for future profitability and debt servicing.

Financial Highlights

debt To Equity
0.43
revenue
$399.0M
operating Margin
-13.9%
total Assets
$1,561.4M
total Debt
$336.1M
net Income
($53.3M)
eps
($3.30)
gross Margin
4.7%
cash Position
$34.4M
revenue Growth
+1.4%

Revenue Breakdown

SegmentRevenueGrowth
Continuing Operations$399.0M+1.4%

Key Numbers

Key Players & Entities

FAQ

Why did Clearwater Paper Corporation report a net loss in Q3 2025?

Clearwater Paper Corporation reported a net loss of $53.3 million for the quarter ended September 30, 2025, primarily due to a significant $48.0 million goodwill impairment charge. This contrasts sharply with a net income of $5.8 million in the same quarter of 2024.

How have Clearwater Paper's cash and cash equivalents changed?

Clearwater Paper's cash and cash equivalents decreased substantially from $79.6 million at December 31, 2024, to $34.4 million at September 30, 2025. This represents a $45.2 million decrease in cash over the nine-month period.

What was the impact of the Augusta, Georgia facility acquisition on Clearwater Paper?

Clearwater Paper completed the acquisition of the Augusta, Georgia paperboard manufacturing facility on May 1, 2024, for a final purchase price of $708.2 million. This acquisition is a key strategic move, and the company is working to integrate it and realize related synergies, efficiencies, and financial benefits.

What are the main risks highlighted in Clearwater Paper's 10-Q filing?

Key risks include the inability to realize expected benefits from the Augusta acquisition, competitive pricing pressures, changes in customer preferences, and increased costs for wood fiber, energy, and freight. The filing also mentions risks associated with PFAS-related litigation at the Augusta facility.

How did the sale of Clearwater Paper's tissue operations affect its financial results?

The sale of Clearwater Paper's tissue operations in November 2024 led to these operations being classified as discontinued. For Q3 2025, discontinued operations contributed $0.6 million in income, significantly down from $16.6 million in Q3 2024, reflecting the settlement of contractual and employment-related obligations post-sale.

What is Clearwater Paper's strategic outlook for the remainder of 2025?

Clearwater Paper anticipates fourth-quarter 2025 operating performance to be influenced by expected sales volumes, product mix, maintenance-outage timing, and energy costs. The company is also focused on realizing benefits from fixed-cost-reduction initiatives and integrating the Augusta facility.

Did Clearwater Paper's net sales increase or decrease in Q3 2025?

Clearwater Paper's net sales from continuing operations increased to $399.0 million for the quarter ended September 30, 2025, up from $393.3 million in the same period of 2024. For the nine months ended September 30, 2025, net sales also increased to $1,169.0 million from $996.5 million in the prior year.

What is the current outstanding common stock for Clearwater Paper?

As of October 27, 2025, the number of shares of common stock of Clearwater Paper Corporation outstanding was 16,038,337. This figure is slightly lower than the 16,568,000 shares issued as of September 30, 2025, due to share repurchases.

What accounting standards are Clearwater Paper evaluating for future impact?

Clearwater Paper is currently evaluating the impact of ASU 2025-05, 'Financial Instruments - Credit Losses', which is effective for annual reporting periods beginning after December 15, 2025. They are also preparing for ASU 2024-03 on 'Disaggregation of Income Statement Expenses' and ASU 2023-09 on 'Improvements to Income Tax Disclosures', which will primarily affect disclosures.

How has Clearwater Paper's long-term debt changed recently?

Clearwater Paper's long-term debt, net, increased from $281.6 million at December 31, 2024, to $335.5 million at September 30, 2025. This increase reflects new borrowings on long-term debt totaling $72.0 million during the nine months ended September 30, 2025.

Risk Factors

Industry Context

Clearwater Paper operates in the paperboard manufacturing sector, serving independent converters. The industry is characterized by cyclical demand, sensitivity to raw material costs (like pulp and energy), and increasing competition. Trends include a focus on sustainable packaging solutions and consolidation among players.

Regulatory Implications

The company faces ongoing regulatory scrutiny related to environmental standards, including emissions and waste management. Compliance with these regulations can lead to significant capital expenditures and operating costs, and any changes in environmental policy could impact profitability.

What Investors Should Do

  1. Monitor cash flow and liquidity closely.
  2. Analyze the impact of the Augusta acquisition and goodwill impairment.
  3. Evaluate the company's debt management strategy.

Key Dates

Glossary

Goodwill Impairment
A charge taken when the carrying value of goodwill on the balance sheet is deemed to be higher than its fair value, indicating a permanent reduction in its value. (A significant $48.0 million charge in Q3 2025 directly led to the net loss, signaling potential overvaluation of past acquisitions or declining future prospects.)
Continuing Operations
The ongoing business activities of a company that are expected to continue into the future, as opposed to discontinued operations. (Net sales growth in continuing operations ($399.0M vs $393.3M) is a key indicator of the core business's performance, despite the overall net loss.)
Discontinued Operations
A segment of a business that a company has sold or plans to sell, and whose results are reported separately from continuing operations. (The sale of the tissue operations impacts the comparability of net income between periods, as income from these operations has significantly decreased.)
Net Sales
The total revenue generated from the sale of goods or services, after deducting returns, allowances, and discounts. (An increase in net sales for continuing operations to $399.0M in Q3 2025 indicates some top-line growth for the core business.)
Cash and Cash Equivalents
Highly liquid investments that are readily convertible to known amounts of cash and which are so near their maturity that they present an insignificant risk of changes in value. (The significant decrease to $34.4M from $79.6M highlights a substantial cash burn and potential liquidity concerns.)
Long-term Debt, Net
The total amount of money borrowed by a company that is due more than one year from the balance sheet date, net of any unamortized discount or premium. (An increase to $335.5M from $281.6M indicates increased leverage, which could heighten financial risk.)

Year-Over-Year Comparison

Compared to the prior year's comparable period, Clearwater Paper has seen an increase in net sales from continuing operations, rising to $399.0 million from $393.3 million. However, this top-line growth is overshadowed by a significant net loss of $53.3 million in Q3 2025, a stark contrast to the $5.8 million net income in Q3 2024, primarily driven by a substantial goodwill impairment charge. The company's financial health also appears strained, with cash and cash equivalents decreasing significantly and long-term debt increasing.

Filing Stats: 4,844 words · 19 min read · ~16 pages · Grade level 8.1 · Accepted 2025-10-28 16:10:02

Key Financial Figures

Filing Documents

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS Our disclosure and analysis in this report contains, in addition to historical information, certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements as to our expectations for fourth-quarter 2025 operating performance, including anticipated sales volumes, product mix, maintenance-outage timing, energy costs and expected benefits from our fixed-cost-reduction initiatives; our cost-reduction and restructuring plan, including the amount and timing of severance and other related charges; our liquidity and capital resources, including our ability to generate cash flows from operations, access borrowing capacity and remain in compliance with financial covenants under our credit agreements; our expected capital expenditures for 2025 and the anticipated timing of such spending; our efforts to integrate the Augusta, Georgia facility and realize related synergies, efficiencies and financial benefits; our belief that the representation-and-warranty insurance claim related to the Augusta acquisition is meritorious and the extent to which we may recover any losses; our expectation that the sale of our tissue operations and related restructuring activities will achieve intended financial and operational outcomes; our ongoing assessment of potential asset dispositions, reorganizations or impairment charges; our expectations regarding labor contract negotiations at the Lewiston, Idaho facility and related retroactive wage adjustments; our evaluation of macroeconomic factors, including the impact of U.S. and foreign tariff and trade policies and related cost changes in energy, chemicals, pulp and freight; our expectations concerning the One Big Beautiful Bill Act ("OBBBA") and other changes in tax law or accounting standards; our expectations with respect to environmental matters, including the PFAS-related litigation involving the Augusta facility and potential insurance recoverie

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Consolidated Financial Statements (Unaudited)

ITEM 1. Consolidated Financial Statements (Unaudited) Consolidated Balance Sheets 2 Consolidated Statements of Operations 3 Consolidated Statements of Comprehensive Income (Loss) 4 Consolidated Statements of Cash Flows 5 Consolidated Statements of Stockholders' Equity 6

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 8

Management's Discussion and Analysis of Financial Condition and Results of Operations

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 18

Quantitative and Qualitative Disclosures About Market Risk

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk 25

Controls and Procedures

ITEM 4. Controls and Procedures 25

OTHER INFORMATION

PART II. OTHER INFORMATION

Legal Proceedings

ITEM 1. Legal Proceedings 26

Risk Factors

ITEM 1A. Risk Factors 26

Unregistered Sales of Equity Securities and Use of Proceeds

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 26

Other Information

ITEM 5. Other Information 26

Exhibits

ITEM 6. Exhibits 27

: Financial Information

Part I: Financial Information

Consolidated Financial Statements

ITEM 1. Consolidated Financial Statements CLEARWATER PAPER CORPORATION Consolidated Balance Sheets (Unaudited) (In millions, except per-share data) September 30, 2025 December 31, 2024 Assets Current assets: Cash and cash equivalents $ 34.4 $ 79.6 Receivables, net of allowance for current expected credit losses 161.7 188.7 Inventories, net 283.2 258.0 Other current assets 8.7 19.1 Total current assets 487.9 545.4 Property, plant and equipment 2,379.5 2,328.4 Accumulated depreciation and amortization ( 1,363.6 ) ( 1,305.4 ) Property, plant and equipment, net 1,015.9 1,023.1 Goodwill and intangible assets, net 2.7 52.9 Other assets, net 54.9 57.9 Total assets $ 1,561.4 $ 1,679.2 Liabilities and stockholders' equity Current liabilities: Current portion of long-term debt $ 0.6 $ 0.6 Accounts payable and accrued liabilities 231.7 319.7 Total current liabilities 232.4 320.4 Long-term debt, net 335.5 281.6 Liability for pension and other postretirement employee benefits 51.6 52.5 Deferred tax liabilities 80.9 89.7 Other long-term obligations 78.2 80.5 Total liabilities 778.5 824.7 Stockholders' equity: Preferred stock, par value $ 0.0001 per share, 5,000,000 authorized shares, no shares issued — — Common stock, par value $ 0.0001 per share, 100,000,000 authorized shares, 16,567,722 shares issued — — Additional paid-in capital 8.2 11.5 Treasury stock, at cost, 529,385 and 122,821 shares ( 14.8 ) ( 3.3 ) Retained earnings 823.9 880.8 Accumulated other comprehensive loss, net of tax ( 34.3 ) ( 34.5 ) Total stockholders' equity 783.0 854.6 Total liabilities and stockholders' equity $ 1,561.4 $ 1,679.2 The accompanying notes are an integral part of these consolidated financial statements. 2 CLEARWATER PAPER CORPORATION Consolidated Statements of Operations (Unaudited) Quarter Ended September 30, Nine Months Ended September 30, (In millions, except per-share data) 2025 2024 2025 2024 Net sales $ 399.0 $ 393.3 $ 1,169.0 $

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements (Unaudited) Note 1 Description of Business and Basis of Presentation Description of Business We are a premier manufacturer and supplier of bleached paperboard focused on servicing independent converters in North America. We also offer services that include custom sheeting, slitting, and cutting. During the year ended December 31, 2024, we sold our tissue (consumer products) operations. Accordingly, the results of our previously-owned tissue operations have been presented as discontinued operations in our Consolidated Statements of Operations for all periods presented. See Note 4, "Discontinued operations." Basis of Presentation The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) for interim financial information. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature. These consolidated financial statements and related Notes should be read in conjunction with our annual report on Form 10-K for the fiscal year ended December 31, 2024. Results of operations for interim periods are not necessarily indicative of results to be expected for an entire year. All dollar amounts are shown in millions, except per share amounts. Note 2 Recently Issued Accounting Standards In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets , which provides a practical expedient permitting entities to assume that conditions at the balance sheet date remain unchanged over the life of the asset when estimating expected credit losses for current accounts receivable. This ASU is effecti

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing